Cryptococcosis in solid organ transplantation.
J W Baddley, G N Forrest, AST Infectious Diseases Community of Practice
https://pubmed.ncbi.nlm.nih.gov/23465017Actively Recruiting
Led by National Institute of Allergy and Infectious Diseases (NIAID) · Updated on 2026-06-05
800
Participants Needed
1
Research Sites
N/A
Total Duration
Cryptococcosis is a fungal infection that mainly affects people with weakened immune systems, like those with AIDS or organ transplants, but about one-third of cases occur in individuals without known immune problems. This research focuses on understanding immune system defects and genetic factors that may make previously healthy adults susceptible to cryptococcosis. The study aims to explore the pathophysiology and immune responses in these patients, including genetic screening of their relatives and comparison with healthy volunteers. Participants include three groups: previously healthy adults diagnosed with cryptococcosis without known immune defects, their blood relatives, and healthy adult volunteers. Various samples such as blood, saliva, cerebrospinal fluid, eyebrow hair, and nail clippings will be collected. Patients will receive standard medical care and may receive corticosteroids or immunosuppressive treatments if inflammation causes neurological damage. Genetic and immunologic testing will be performed to identify immune abnormalities and genetic susceptibility. Participants will be closely monitored with various tests to understand disease progression and immune responses. Healthy volunteers and relatives will also undergo testing to serve as comparison groups. The study will measure clinical disease spectrum and investigate immunological and genetic mechanisms over 1 to 5 years. Participants may be seen frequently as needed to manage their condition, and samples will be stored for future research.
CONDITIONS
Fungal Infection Susceptibility
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 5 years
Participants provide biological samples such as saliva, blood, eyebrow hair, cerebrospinal fluid (CSF), and nail clippings for immune and genetic testing.
Visits as needed over the course of the study
Duration - 1 to 5 years
Participants are observed over time to understand disease progression, immune response, and genetic factors related to cryptococcosis.
Visits as often as necessary for medical management and assessments
Total: 1 location
1
National Institutes of Health Clinical Center
Bethesda, Maryland, United States, 20892
Actively Recruiting
P
Peter R Williamson, M.D.
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
J W Baddley, G N Forrest, AST Infectious Diseases Community of Practice
https://pubmed.ncbi.nlm.nih.gov/23465017Benjamin J Park, Kathleen A Wannemuehler, Barbara J Marston...
https://pubmed.ncbi.nlm.nih.gov/19182676John R Perfect, William E Dismukes, Francoise Dromer...
https://pubmed.ncbi.nlm.nih.gov/20047480Kyle D Brizendine, John W Baddley, Peter G Pappas
https://pubmed.ncbi.nlm.nih.gov/23555970Emily W Bratton, Nada El Husseini, Cody A Chastain...
https://pubmed.ncbi.nlm.nih.gov/22937064F P Gullo, S A Rossi, J de C O Sardi...
https://pubmed.ncbi.nlm.nih.gov/24141976J W Baddley, J R Perfect, R A Oster...
https://pubmed.ncbi.nlm.nih.gov/18449582Sharon C-A Chen, Tony M Korman, Monica A Slavin...
https://pubmed.ncbi.nlm.nih.gov/23697747Peter G Pappas
https://pubmed.ncbi.nlm.nih.gov/23874010Joseph Meletiadis, Thomas J Walsh, Eun Hwa Choi...
https://pubmed.ncbi.nlm.nih.gov/17710620